Navigation Links
Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
Date:3/10/2010

NEW YORK, March 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 22nd Annual ROTH OC Growth Stock Conference, being held in Laguna Niguel, CA. Mr. Bentsur's presentation will take place on Tuesday March 16, 2010 at 8:00 a.m. PT (11:00 am ET).


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
2. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
3. Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma
4. Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
5. Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
9. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 1, 2015 Inventor of ... ana team   NuCana, a clinical ... and commercialise a portfolio of novel anti-cancer medicines, today ... as Chief Scientific Officer. Professor McGuigan was ... currently Professor of Medicinal Chemistry at the Cardiff School ...
(Date:6/30/2015)... June 30, 2015 Nortek Security & ... NTK ) and a leader in the residential ... announced it acquired mobile personal emergency response system ... Numera, Inc. Headquartered in ... implemented, mobile PERS products and cloud-based software platforms ...
(Date:6/30/2015)... 2015   Millar, Inc. , a leader in ... 2016 retirement of Craig Thummel , President/CEO and ... of service to the Company. The Company also announced ... of the Executive Management team as his successors. The ... currently Director of Sales and Marketing, as President, and ...
Breaking Medicine Technology:Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow of ... August 15-16th (MSG Keys’ birthday) in memory of her late husband and all of ... recipient of the Bronze Star Medal, died during a Special Forces training exercise in ...
(Date:7/1/2015)... KY (PRWEB) , ... July 01, 2015 , ... ... Care Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying the ... paper was published July 1st and is available at: http://www.hcttf.org/resouces-tools . , ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... has just published a top ten list they hope will guide future mesothelioma ... here to read it now. , More than 450 mesothelioma patients, ...
(Date:7/1/2015)... ... 01, 2015 , ... B. E. Smith, the only full-service ... a national chief executive officer recruitment for Citizens Medical Center in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is pleased ... weighing pans, ML-T balances give operators the room they need to carry out ... estate makes ML-T balances a perfect choice for day-to-day weighing in nearly any ...
Breaking Medicine News(10 mins):Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2
... partly to blame for the conflict in Sudan's Darfur ... U.N. Secretary-General Ban Ki-moon said in an editorial published ... in convenient military and political shorthand - an ethnic ... Ban wrote in The Washington Post. "Look to its ...
... identified individual genes that are associated with resistance to ... that may significantly enhance the ability to predict ... treatment,using a functional genomic screen. ,Resistance to ... in patients with metastatic cancer. Dr. Julian Downward from ...
... and TV presenter Charlotte Church has been preparing her playlist of ... if reports have to be believed . ,It seems ... with beau Gavin Henson, hopes that the iTunes will help her ... insider said that the Rugby star had consulted his friends, who ...
... announced that the wrappers of the diabetes drug Avandia will ... risk of congestive heart failure . ,Some of ... FDA, feel that the delay in implementation is an example ... loser. ,GlaxoSmithKline's Avandia has been in use since ...
... cancer, has been conferred the honor of CBE in the ... Leeds in UK , was first diagnosed with breast cancer ... returned to haunt her a decade later, spreading to her ... was told six years ago. ,But undaunted she ...
... (RIA Novosti) Astronauts from the Atlantis space shuttle have ... Station (ISS), a spokesperson for the US National Aeronautics ... ,During the space walk, astronauts Patrick Forrester and Steven ... (SARJ), allowing solar arrays installed earlier to rotate towards ...
Cached Medicine News:Health News:Climatic Change Cause of Dafur Conflict-UN 2Health News:New Genetic Studies Carried Out in Cancer Therapy 2Health News:42-year-old Cancer Patient Honored by British Queen for Her Fundraising Efforts 2
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
... tip cannula allows atraumatic access ... for aspiration of subretinal fluids. ... beyond end of cannula. ... secure connection to a backflush ...
Medicine Products: